Aaron Freidin (Officer) plans to sell ~$3.46M of Grail
Planned, from payLoading…
GRAL · NASDAQ · Services-Medical Laboratories
Services-Medical Laboratories company based in Sunnyvale, Ca.
In the last 90 days, no insider of Grail reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 6, 2026
$137.28
Last 12 months
Not enough history
Market value
Not available
Bets against the stock: 8.57M shares sold short, +0.6% vs the previous count, 12.7 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$44.7M
+25.7% vs the same quarter a year earlier
Free cash flow, last 12 months
−$296M
This quarter −$81.2M, a year earlier −$77.3M
Net debt
—
Debt —, cash $55.6M, at Jun 30, 2026
Net income, last 12 months
−$392M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 5, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Aaron Freidin (Officer) plans to sell ~$3.46M of Grail
Planned, from payAndrew Partridge (Officer) plans to sell ~$1.15M of Grail
Planned, from payPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.